Literature DB >> 7231823

Functioning ovarian tumors in postmenopausal women.

R M Rome, D W Fortune, M A Quinn, J B Brown.   

Abstract

Estrogen excretion was higher than normal (more than 9 microgram/24 hr) in 40 of 80 postmenopausal women with benign and malignant epithelial tumors of the ovary, including 8 metastatic tumors. High estrogen excretion was noted in 19 of 27 (70.4%) patients with mucinous tumors in only 1 of 25 (4%) patients with serous tumors (P less than .001). Endometrioid and metastatic tumors were also noted to be frequently associated with high estrogen excretion. In the high estrogen excretion group 27 of 37 (73%) patients showed stromal luteinization and/or condensation in the tumor, but in the normal estrogen excretion group these changes were seen in only 6 of 38 (15.8%) patients (P less than .001). A possible mechanism of stromal stimulation in these tumors is discussed. Although there was often evidence of estrogen activity in the endometrium and the tubal epithelium in the high estrogen excretion group, the correlation between these epithelia and estrogen excretion was imperfect. Postoperative estrogen excretion remained elevated in 3 of 16 patients, of whom 1 was obese and 2 had residual tumor. This study emphasizes the importance of identifying epithelial tumors of the ovary as functioning or endocrine tumors.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7231823

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  8 in total

1.  Hormonal aspects of ovarian malignancy.

Authors:  J Waxman
Journal:  J R Soc Med       Date:  1984-03       Impact factor: 5.344

Review 2.  Hormone-producing tumors of the ovary.

Authors:  Ara Chalvardjian
Journal:  Endocr Pathol       Date:  1990-09       Impact factor: 3.943

3.  Human ovarian cancer stroma contains luteinized theca cells harboring tumor suppressor gene GT198 mutations.

Authors:  Min Peng; Hao Zhang; Lahcen Jaafar; John I Risinger; Shuang Huang; Nahid F Mivechi; Lan Ko
Journal:  J Biol Chem       Date:  2013-10-04       Impact factor: 5.157

4.  Diagnostic significance of steroid hormones in patients with ovarian cancer.

Authors:  D Mango; P Scirpa; F Battaglia; E Tartaglia; P Manna
Journal:  J Endocrinol Invest       Date:  1986-08       Impact factor: 4.256

5.  A case of mucinous cystadenocarcinoma of the ovary associated with virilization: pre and post-operative steroid plasma levels.

Authors:  D Mango; P Scirpa; F Battaglia; S Sentinelli; E Menini
Journal:  J Endocrinol Invest       Date:  1985-08       Impact factor: 4.256

6.  Large functional benign endometroid cystadenofibroma of the ovary leading to endometrial cystic glandular hyperplasia and postmenopausal bleeding.

Authors:  Nilanchali Singh; Reva Tripathi; Yedla Manikya Mala; Neeta Khurana; Mumtaz Khan
Journal:  BMJ Case Rep       Date:  2013-06-11

7.  Hormonally Functional Ovarian Neoplasms.

Authors:  Lawrence M. Roth; Steven D. Billings
Journal:  Endocr Pathol       Date:  2000       Impact factor: 3.943

8.  Estrogen-producing endometrioid adenocarcinoma resembling sex cord-stromal tumor of the ovary: a review of four postmenopausal cases.

Authors:  Tomomi Katoh; Masanori Yasuda; Kosei Hasegawa; Eito Kozawa; Jun-ichi Maniwa; Hironobu Sasano
Journal:  Diagn Pathol       Date:  2012-11-28       Impact factor: 2.644

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.